1,710 followers
bromodomain inhibitors as therapy in double-hit lymphoma. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. - PubMed - NCBI https://t.co/VMrzAeovBO
bromodomain inhibitors as therapy in double-hit lymphoma. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. - PubMed - NCBI https://t.co/VMrzAeovBO
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. #lymphoma #lymsm https://t.co/Ge4Fo57ad0